| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.74▲ | 0.74▲ | 0.74▲ | 0.75▼ | 0.78▼ |
| MA10 | 0.75▲ | 0.75▲ | 0.75▼ | 0.77▼ | 0.79▼ |
| MA20 | 0.76▼ | 0.76▼ | 0.77▼ | 0.80▼ | 0.91▼ |
| MA50 | 0.80▼ | 0.80▼ | 0.80▼ | 0.81▼ | 0.86▼ |
| MA100 | 0.80▼ | 0.80▼ | 0.79▼ | 0.88▼ | 2.27▼ |
| MA200 | 0.78▼ | 0.80▼ | 0.82▼ | 0.81▼ | 7.47▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.000▼ | -0.002▼ | -0.007▼ | -0.007▼ |
| RSI | 41.981▼ | 42.862▼ | 42.419▼ | 42.747▼ | 44.581▼ |
| STOCH | 43.076 | 43.076 | 29.066 | 13.193▼ | 37.974 |
| WILL %R | -51.042 | -52.457 | -56.016 | -78.524▼ | -87.440▼ |
| CCI | -25.347 | -25.757 | -39.722 | -96.408 | -85.764 |
|
Thursday, February 26, 2026 08:00 AM
Detailed price information for Pasithea Therapeutics Corp (KTTA-Q) from The Globe and Mail including charting and trades.
|
|
Saturday, February 21, 2026 08:52 AM
Detailed price information for Pasithea Therapeutics Corp (KTTA-Q) from The Globe and Mail including charting and trades.
|
|
Friday, December 19, 2025 04:00 PM
The average one-year price target for Pasithea Therapeutics (NasdaqCM:KTTA) has been revised to $3.06 / share. This is an increase of 50.00% from the prior estimate of $2.04 dated August 1, 2023. The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/03/26 | 0.7438 | 0.75 | 0.7433 | 0.75 | 88,829 |
| 30/03/26 | 0.7349 | 0.755 | 0.7145 | 0.715 | 36,981 |
| 27/03/26 | 0.75 | 0.7773 | 0.74 | 0.74 | 68,761 |
| 26/03/26 | 0.799 | 0.81 | 0.7652 | 0.778 | 58,860 |
| 25/03/26 | 0.751 | 0.7891 | 0.751 | 0.7813 | 26,613 |
| 24/03/26 | 0.767 | 0.7854 | 0.751 | 0.7658 | 724,909 |
| 23/03/26 | 0.7999 | 0.7999 | 0.7551 | 0.77 | 35,833 |
| 20/03/26 | 0.765 | 0.8117 | 0.7576 | 0.797 | 190,424 |
| 19/03/26 | 0.8102 | 0.8698 | 0.7602 | 0.7821 | 114,537 |
| 18/03/26 | 0.843 | 0.8552 | 0.82 | 0.82 | 76,552 |
|
|
||||
|
|
||||
|
|